{"database": "lobbying", "table": "lobbying_activities", "rows": [[821704, "85f11362-2a3e-4747-add2-d3d633ceafd7", "Q3", "HOLLAND & KNIGHT LLP", 18466, "SHIRE PHARMACEUTICALS, INC", 2009, "third_quarter", "HCR", "Worked on H.R. 1548, Pathway for Biosimilars Act; H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act; seek amendment regarding biologics in rare diseases; supported amendment incorporating these provisions into H.R. 3200, America's Affordable Health Choices Act of 2009 and the Affordable Health Choices Act in the Senate.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2009-10-01T10:35:18-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["821704"], "units": {}, "query_ms": 0.4726429469883442, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}